Printer Friendly

COMPANY INFORMATION
Tekmira Pharmaceuticals Corporation 200-8900 Glenlyon Pky Burnaby, BC V5J 5J8 Tel: (604) 419-3200 Fax: (604) 419-3201 Contact Name Ian C. Mortimer Industry Pharmaceuticals		Key Executives Mark J. Murray, CEO Ian C. Mortimer, CFO Develops and commercializes proprietary drugs and drug delivery systems to treat cancer and other diseases. The company develops product candidates using oligonucleotides combined with SNALP, its proprietary lipid nanoparticle delivery technology to treat disease by either stimulating the immune system or preventing the production of proteins that are linked to diseases, through a process known as RNA interference (RNAi). Oligonucleotides are short sequences of nucleic acids, deoxyribonucleic acid (DNA) or ribonucleic acid (RNA).
FP ADVISOR COVERAGE Tekmira Pharmaceuticals Corporation • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Investor Reports • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/TKM $0.75 $1.49 $0.56 n.a. n.a. n.a. n.a. Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 60,277 n.a. $-0.23 Sept. 30/09 20.97% n.a. n.a. $38,722
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/061 $000s $000s $000s Operating revenue 11,732 15,769 15,857 Net income (14,261) (2,558) 21,075 Total assets 51,530 24,593 7,034 $ $ $ Earnings per share* (0.35) (0.11) 1.10 % % % Return on equity (44.02) (27.85) n.m.   * Common 1 Results prior to Apr. 30, 2007, pertain to Inex Pharmaceuticals Corporation.
TRAILING 12-MONTH VALUES Periods ended: Sept. 30/09 Sept. 30/08 $000s $000s Operating revenue 13,022 12,853 Net income (10,121) (10,937) $ $ Earnings per share (0.22) (0.27)

COMPANY NEWS

Results for 'Tekmira Pharmaceuticals Corporation' from past 30 days: No hits. (Links are to articles.)